Restoration of ER expression and antiestrogen response in ER-negative breast cancer

被引：0
|
作者：
Bayliss, Jill [1 ]
Hilger, Amy [1 ]
El-Ashry, Dorraya [1 ]
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2934
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Targeting the mTOR pathway for the prevention of er-negative breast cancer
    Mazumdar, Abhijit
    Hill, Jamal
    Tahaney, William
    Ma, Yanxia
    Contreras, Alejandro
    Sei, Shizuko
    Mohammed, Altaf
    Brown, Powel
    CANCER RESEARCH, 2022, 82 (12)
  • [22] Reversal of the ER-negative phenotype in breast cancer by inhibition of MAPK
    Brinkman, Joeli
    El-Ashry, Dorraya
    CANCER RESEARCH, 2009, 69
  • [23] Interleukin-8 in progression of ER-positive and ER-negative breast cancer patients
    Todorovic-Rakovic, N.
    Milovanovic, J.
    Abu Rabi, Z.
    EUROPEAN JOURNAL OF CANCER, 2016, 57 : S115 - S115
  • [24] Prognostic Impact of HOTAIR Expression is Restricted to ER-Negative Breast Cancers
    Yesim Gökmen-Polar
    I. Tudor Vladislav
    Yaseswini Neelamraju
    Sarath C. Janga
    Sunil Badve
    Scientific Reports, 5
  • [25] Prognostic Impact of HOTAIR Expression is Restricted to ER-Negative Breast Cancers
    Goekmen-Polar, Yesim
    Vladislav, I. Tudor
    Neelamraju, Yaseswini
    Janga, Sarath C.
    Badve, Sunil
    SCIENTIFIC REPORTS, 2015, 5
  • [26] ER Re-expression and Re-sensitization to Endocrine Therapies in ER-negative Breast Cancers
    Brinkman, Joeli A.
    El-Ashry, Dorraya
    JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2009, 14 (01) : 67 - 78
  • [27] ER Re-expression and Re-sensitization to Endocrine Therapies in ER-negative Breast Cancers
    Joeli A. Brinkman
    Dorraya El-Ashry
    Journal of Mammary Gland Biology and Neoplasia, 2009, 14 : 67 - 78
  • [28] CD133 expression is associated with less DNA repair, better response to chemotherapy, and survival in ER-positive/ER-negative breast cancer
    Sato, Takumi
    Oshi, Masanori
    Lee, Jing
    Roy, Arya M.
    Chida, Kohei
    Endo, Itaru
    Obayashi, Masato
    Takabe, Kazuaki
    CANCER RESEARCH, 2024, 84 (06)
  • [29] ER-Negative Breast Cancer Is Highly Responsive to Cholesterol Metabolite Signalling
    Hutchinson, Samantha A.
    Lianto, Priscilia
    Roberg-Larsen, Hanne
    Battaglia, Sebastiano
    Hughes, Thomas A.
    Thorne, James L.
    NUTRIENTS, 2019, 11 (11)
  • [30] Prevention of ER-negative breast cancer: where do we stand?
    Cazzaniga, Massimiliano
    Bonanni, Bernardo
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2012, 21 (02) : 171 - 181
12345